Advanced Filters
noise
Found 65,447 clinical trials

A Phase 1 Study of FZ008-145 in Healthy Subjects.

The study will be conducted in 5 parts: Part A (single ascending dose [SAD] in solution formulation), Part B (SAD in tablet formulation), Part C (food effect [FE]), Part D (cold pressor test [CPT] to evaluate pain tolerance following single dose), and Part E (multiple ascending dose [MAD] in tablet …

18 - 65 years of age All Phase 1
R Rahma MKHININI, Clinical Research Assistant

Evaluation of the Efficacy of Therapeutic Infiltrations of the Pudendal Nerve, Performed Under Neurostimulation on Pain, 1 Month After an Infiltration of Local Anaesthetic, in the Treatment of Pudendal Neuralgia.

Pudendal neuralgia (PN) is a chronic nerve compression syndrome causing neuropathic pain. Treatment includes medication, infiltration and decompressive surgery. Medicinal treatment involves the use of drugs that have proved effective in other areas, such as shingles or diabetes. There is no consensus on the molecules to be used for pudendal …

18 years of age All Phase 3
H Hesham Elgoweini, PhD

Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema

The purpose of this clinical study is to explore the efficacy of dapagliflozin as an adjunct to intravitreal anti-vascular endothelial growth factor (anti-VEGF) for enhanced reduction of retinal thickness and vision improvement in patients with diabetic macular edema. The main question the study aims to answer is: Does dapagliflozin reduce …

18 - 85 years of age All Phase 2
T Tracey J Smith, PhD

Bioavailability of Ration Items Containing Tart Cherry Extract

To determine how consuming food items containing shelf-stored tart cherry impacts your body's ability to absorb and use the compounds within tart cherry.

17 - 39 years of age All Phase N/A
P Per Reidar Høiness, MD Phd

A Needle Technique for Achilles Tendon Lengthening in Pediatric Patients: A Prospective Study on Efficacy, Safety, and Feasibility

For years, we have used a minimally invasive and biological variant of Achilles tendon lengthening using a needle inserted into the Achilles tendon so that it is weakened and can be gradually stretched to the desired length. So far, no negative effects, complications or tendon problems have been observed. A …

5 - 16 years of age All Phase N/A
S Sheba

Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes

A Multiple Dose, Randomized, Placebo-controlled, Dose-escalating Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered MD-18 for healthy subjects with overweight or obesity

18 - 70 years of age All Phase 1
A André Mouraux, PhD

Disentangling the Variability of Exercise-induced Hypoalgesia: the Role of Circulatory Compounds

Physical exercise is increasingly recognized as an effective treatment for chronic pain. Studies in humans and animals have shown that a single session of exercise induces a reduction of sensitivity to experimental painful stimuli lasting up to 45 minutes. In a recent study conducted in our laboratory, we found (1) …

18 - 30 years of age All Phase N/A
C Christos Tsakalidis, Professor

Lactase-Assisted Control Trial On Weight GAin in INfants.

Lactose, a disaccharide that includes the monosaccharides glucose and galactose, is the main carbohydrate found exclusively in mammalian milk. Lactase is found in the intestinal mucosa and is located at the ends of the villi, while it is a factor of maximum clinical importance in milk tolerance and in the …

1 - 4 years of age All Phase N/A
X Xingshun Qi, MD

Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)

Hepatic encephalopathy (HE), a severe complication of decompensated cirrhosis, is characterized as neurocognitive dysfunction. Emerging evidence suggests the potential role of human albumin infusion for the treatment of HE, but its optimal dosage remains undefined. Therefore, the investigators planned a randomized controlled trial (RCT) to compare the efficacy of human …

18 years of age All Phase N/A
P Participant Recruitment Agent

A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy Participants

This study aims to assess the safety and tolerability of ABCL575 in healthy participants following single ascending dose (SAD), in comparison to a placebo

18 - 65 years of age All Phase N/A

Simplify language using AI